Total Payments
$42,118
2024 Payments
$768.01
Companies
11
Transactions
152
Medicare Patients
4,166
Medicare Billing
$485,696
Payment Breakdown by Category
Other$37,616 (89.3%)
Food & Beverage$3,008 (7.1%)
Travel$1,449 (3.4%)
Consulting$45.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $35,670 | 26 | 84.7% |
| Food and Beverage | $3,008 | 118 | 7.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,946 | 4 | 4.6% |
| Travel and Lodging | $1,449 | 3 | 3.4% |
| Consulting Fee | $45.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $40,878 | 102 | $0 (2023) |
| Amgen Inc. | $662.06 | 33 | $0 (2024) |
| Alcon Vision LLC | $220.61 | 2 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $115.33 | 4 | $0 (2023) |
| Merz North America, Inc. | $64.39 | 3 | $0 (2019) |
| Galderma Laboratories, L.P. | $49.61 | 1 | $0 (2017) |
| Shire North American Group Inc | $45.49 | 3 | $0 (2017) |
| Merz Pharmaceuticals, LLC | $33.75 | 1 | $0 (2022) |
| Pacira Pharmaceuticals Incorporated | $18.01 | 1 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $17.35 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $768.01 | 36 | Amgen Inc. ($662.06) |
| 2023 | $5,965 | 39 | Horizon Therapeutics plc ($5,877) |
| 2022 | $2,619 | 23 | Horizon Therapeutics plc ($2,408) |
| 2021 | $9,262 | 19 | Horizon Therapeutics plc ($9,262) |
| 2020 | $23,330 | 27 | Horizon Therapeutics plc ($23,317) |
| 2019 | $34.28 | 2 | Merz North America, Inc. ($19.72) |
| 2018 | $21.47 | 1 | Merz North America, Inc. ($21.47) |
| 2017 | $118.30 | 5 | Galderma Laboratories, L.P. ($49.61) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/05/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/13/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/31/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/22/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $88.72 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/22/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $88.72 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $0.69 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/05/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $4.92 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/22/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/22/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $1.71 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/17/2024 | Alcon Vision LLC | TOTAL30 (Device), DAILIES TOTAL1, Precision 1 | Food and Beverage | In-kind items and services | $70.59 | General |
| Category: Ophthalmology | ||||||
| 07/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $2.19 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $2.19 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/15/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $3.14 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/24/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Pain Management | ||||||
| 05/31/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Ophthalmology | ||||||
| 05/22/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $8.81 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,069 | 2,662 | $481,412 | $128,787 |
| 2022 | 12 | 1,089 | 3,135 | $479,477 | $134,455 |
| 2021 | 11 | 1,022 | 3,575 | $446,424 | $122,017 |
| 2020 | 12 | 986 | 3,279 | $478,592 | $100,437 |
Total Patients
4,166
Total Services
12,651
Medicare Billing
$485,696
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2023 | 64 | 64 | $182,400 | $37,886 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 203 | 311 | $46,650 | $26,118 | 56.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 189 | 189 | $36,666 | $20,043 | 54.7% |
| 67903 | Shortening or advancement of upper eyelid muscle to correct drooping or paralysis | Facility | 2023 | 26 | 26 | $81,511 | $12,596 | 15.5% |
| 67840 | Removal of growth of eyelid | Office | 2023 | 31 | 38 | $14,896 | $6,732 | 45.2% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 147 | 155 | $17,980 | $6,320 | 35.2% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2023 | 11 | 1,420 | $13,150 | $5,538 | 42.1% |
| 92285 | Photography of content of eyes | Office | 2023 | 323 | 356 | $28,836 | $4,655 | 16.1% |
| 67917 | Extensive repair of turning-outward eyelid defect | Facility | 2023 | 12 | 12 | $21,964 | $3,637 | 16.6% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 11 | 29 | $18,700 | $2,762 | 14.8% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2023 | 29 | 39 | $3,744 | $1,472 | 39.3% |
| 67875 | Temporary closure of eyelids by suture | Facility | 2023 | 23 | 23 | $14,915 | $1,028 | 6.9% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2022 | 69 | 69 | $198,550 | $41,568 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 201 | 326 | $46,140 | $28,204 | 61.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 200 | 200 | $35,553 | $21,375 | 60.1% |
| 67903 | Shortening or advancement of upper eyelid muscle to correct drooping or paralysis | Facility | 2022 | 23 | 23 | $73,801 | $11,075 | 15.0% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2022 | 13 | 1,835 | $11,928 | $7,072 | 59.3% |
| 67840 | Removal of growth of eyelid | Office | 2022 | 24 | 36 | $14,520 | $6,283 | 43.3% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 135 | 142 | $16,472 | $5,735 | 34.8% |
| 92285 | Photography of content of eyes | Office | 2022 | 347 | 374 | $30,294 | $4,880 | 16.1% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 13 | 44 | $30,250 | $4,768 | 15.8% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2022 | 26 | 48 | $4,608 | $2,002 | 43.4% |
| 67875 | Temporary closure of eyelids by suture | Facility | 2022 | 25 | 25 | $15,893 | $1,162 | 7.3% |
| 92133 | Imaging of optic nerve | Office | 2022 | 13 | 13 | $1,469 | $330.08 | 22.5% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2021 | 46 | 46 | $184,300 | $28,690 | 15.6% |
About Dr. Mark Brown, MD
Dr. Mark Brown, MD is a Ophthalmology healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114999729.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Brown, MD has received a total of $42,118 in payments from pharmaceutical and medical device companies, with $768.01 received in 2024. These payments were reported across 152 transactions from 11 companies. The most common payment nature is "Honoraria" ($35,670).
As a Medicare-enrolled provider, Brown has provided services to 4,166 Medicare beneficiaries, totaling 12,651 services with total Medicare billing of $485,696. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Ophthalmology
- Location Mobile, AL
- Active Since 02/07/2006
- Last Updated 10/24/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1114999729
Products in Payments
- TEPEZZA (Drug) $39,098
- TEPEZZA (Biological) $662.06
- TOTAL30 (Device) $220.61
- Cequa (Drug) $115.33
- Xeomin (Biological) $56.95
- XIIDRA (Drug) $45.49
- XEOMIN (Biological) $41.19
- Exparel (Drug) $18.01
- MIEBO (Drug) $17.35
- rhopressa (Drug) $13.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Mobile
Alan Franklin, M.d., Phd, M.D., PHD
Ophthalmology — Payments: $124,023
Ophthalmology $124,023
Dr. Paul Taupeka, M.d, M.D
Ophthalmology — Payments: $7,760
Ophthalmology $7,760
Peter Zloty, M.d, M.D
Ophthalmology — Payments: $7,121
Ophthalmology $7,121
Mark Douglas, M.d, M.D
Ophthalmology — Payments: $4,973
Ophthalmology $4,973
Mr. Charles Salisbury, Md, MD
Ophthalmology — Payments: $4,684
Ophthalmology $4,684
Curtis Graf, M.d, M.D
Ophthalmology — Payments: $4,101
Ophthalmology $4,101